olmesartan medoxomil NDC 50228-341

Product information

Brand name (proprietary)

olmesartan medoxomil

Generic name (nonproprietary)

olmesartan medoxomil

Active ingredients

Olmesartan medoxomil — 40 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

ScieGen Pharmaceuticals, Inc.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 208130

Marketing start

Jun 29, 2018

Listing expires

Dec 31, 2026

Other FDA classes

Angiotensin 2 Receptor Antagonists (Mechanism)

Identifiers

Product ID 50228-341_b866b8df-72d9-2de9-e053-2995a90a3d70SPL ID b866b8df-72d9-2de9-e053-2995a90a3d70SPL set ID f15664a4-6b5f-4e88-ad56-c827ed90a40cRxCUI 349373, 349401, 349405UNII 6M97XTV3HDUPC 0350228340304, 0350228341301, 0350228339308, 0350228340908, 0350228339100, 0350228339902, 0350228341905

Pharmacologic class

Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450228034110 followed by a unit qualifier and the quantity Copy

Package 50228-0341-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 208130

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.